Hans Olivecrona
Chief Tech/Sci/R&D Officer chez KLARIA PHARMA HOLDING AB
Profil
Hans Olivecrona is currently the Chief Medical Officer at Klaria Pharma Holding AB since 2022.
Prior to this, he worked as the Senior Medical Director at Swedish Orphan Biovitrum AB.
From 2017 to 2020, he was the Chief Medical Officer at PCI Biotech Holding ASA. He also held the position of Chief Medical Officer at Immedica Pharma AB.
Dr. Olivecrona obtained his doctorate degree from Karolinska Institutet.
Postes actifs de Hans Olivecrona
Sociétés | Poste | Début |
---|---|---|
KLARIA PHARMA HOLDING AB | Chief Tech/Sci/R&D Officer | 01/03/2022 |
Anciens postes connus de Hans Olivecrona
Sociétés | Poste | Fin |
---|---|---|
PCI BIOTECH HOLDING ASA | Chief Tech/Sci/R&D Officer | 01/05/2020 |
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Chief Tech/Sci/R&D Officer | - |
SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | - |
Formation de Hans Olivecrona
Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
PCI BIOTECH HOLDING ASA | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
KLARIA PHARMA HOLDING AB | Health Technology |
Entreprise privées | 1 |
---|---|
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Distribution Services |